These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10544762)

  • 1. [Immunohistochemical evaluation of the in vitro bromodeoxyuridine labeling index. 236 breast cancers studies by image analysis].
    Birtwisle-Peyrottes I; Rostagno P; Granon C; Moll JL; Formento JL; Ettore F
    Ann Pathol; 1999 Sep; 19(4):283-8. PubMed ID: 10544762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index.
    Beauregard P; Witzig TE; Kurtin PJ; Greipp PR; Stenson MJ; Katzmann JA; Habermann TM; Wieand HS
    Hematol Pathol; 1991; 5(4):177-83. PubMed ID: 1794967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
    Shyr YM; Su CH; Li AF; Wu CW; Lui WY
    Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
    Waldman FM; Chew K; Ljung BM; Goodson W; Hom J; Duarte LA; Smith HS; Mayall B
    Mod Pathol; 1991 Nov; 4(6):718-22. PubMed ID: 1724086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases.
    Caly M; Genin P; Ghuzlan A A; Elie C; Fréneaux P; Klijanienko J; Rosty C; Sigal-Zafrani B; Vincent-Salomon A; Douggaz A; Zidane M; Sastre-Garau X
    Anticancer Res; 2004; 24(5B):3283-8. PubMed ID: 15510624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas.
    Cutress RI; Mullee MA; Royle GT; Rew DA
    Eur J Surg Oncol; 2000 Dec; 26(8):747-50. PubMed ID: 11087639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.
    Lehr HA; Jacobs TW; Yaziji H; Schnitt SJ; Gown AM
    Am J Clin Pathol; 2001 Jun; 115(6):814-22. PubMed ID: 11392876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
    Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
    Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T; Harijadi ; Ghozali A
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation measurement in breast cancer by two different methods.
    Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J
    Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP; Hoop JG; Nap M
    Anticancer Res; 2003; 23(2A):999-1006. PubMed ID: 12820338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity in primary breast carcinomas is a salient prognostic factor.
    Michels JJ; Marnay J; Delozier T; Denoux Y; Chasle J
    Cancer; 2004 Feb; 100(3):455-64. PubMed ID: 14745860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers.
    Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S
    Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.